Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-28
DOI
10.1007/s10549-019-05284-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update
- (2018) Neelima Denduluri et al. JOURNAL OF CLINICAL ONCOLOGY
- Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- (2018) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining Survivorship Trajectories Across Patients With Solid Tumors
- (2018) Robert L. Dood et al. JAMA Oncology
- Recurrence dynamics of breast cancer according to baseline body mass index
- (2017) Elia Biganzoli et al. EUROPEAN JOURNAL OF CANCER
- HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2
- (2017) John M.S. Bartlett et al. EUROPEAN JOURNAL OF CANCER
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Miguel Martin et al. LANCET ONCOLOGY
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
- (2017) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic and predictive biomarkers in breast cancer: Past, present and future
- (2017) Andrea Nicolini et al. SEMINARS IN CANCER BIOLOGY
- Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are going
- (2016) Francesco Schettini et al. CANCER TREATMENT REVIEWS
- Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
- (2016) Martine Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
- A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers
- (2016) Anthony Ferrari et al. Nature Communications
- Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab
- (2016) Sherene Loi et al. JAMA Oncology
- Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy
- (2015) M. Giuliano et al. CLINICAL CANCER RESEARCH
- Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008
- (2015) Rachel J.D. Cossetti et al. JOURNAL OF CLINICAL ONCOLOGY
- Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression
- (2015) M. C. U. Cheang et al. ONCOLOGIST
- Which threshold for ER positivity? a retrospective study based on 9639 patients
- (2014) M. Yi et al. ANNALS OF ONCOLOGY
- Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX
- (2013) Otto Metzger-Filho et al. JOURNAL OF CLINICAL ONCOLOGY
- Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?
- (2012) I. Vaz-Luis et al. ANNALS OF ONCOLOGY
- Effect of HER2 status on distant recurrence in early stage breast cancer
- (2012) Kenneth R. Hess et al. BREAST CANCER RESEARCH AND TREATMENT
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status
- (2009) Yeon Hee Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
- (2008) M. Untch et al. ANNALS OF ONCOLOGY
- Identification of brain- and bone-specific breast cancer metastasis genes
- (2008) Andreas Klein et al. CANCER LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now